Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - glatiramer acetate - solution for injection in pre-filled syringe - 20 milligram(s)/millilitre - other immunostimulants; glatiramer acetate

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - glatiramer acetate - solution for injection in pre-filled syringe - other immunostimulants; glatiramer acetate

Israel - English - Ministry of Health

teva israel ltd - glatiramer acetate - solution for injection - glatiramer acetate 20 mg/ml - glatiramer acetate - glatiramer acetate - for reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (cdms). these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - glatiramer acetate - solution for injection - glatiramer acetate 20 mg/dose - glatiramer acetate - glatiramer acetate - for reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (cdms). these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.

Israel - English - Ministry of Health

takeda israel ltd - mifamurtide - powder for concentrate for dispersion for infusion - mifamurtide 4 mg/vial - mifamurtide - mifamurtide - mepact is indicated in children, adolescents and young adults for the treatment of high grade resectable non metastatic osteosarcoma after macroscopically complete surgical resection. it is used in combination with post operative multi-agent chemotherapy. safety and efficacy have been assessed in studies of patients 2 to 30 years of age at initial diagnosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharmaceuticals limited - glatiramer acetate - solution for injection - 20 mg/ml - other immunostimulants

Malta - English - Malta Medicines Authority

teva pharmaceuticals limited ridings point, whistler drive, castleford, west yorkshire wf10 5hx, united kingdom - glatiramer acetate - solution for injection - glatiramer acetate 20 mg/ml - immunostimulants

Malta - English - Malta Medicines Authority

teva pharmaceuticals limited ridings point, whistler drive, castleford, west yorkshire wf10 5hx, united kingdom - glatiramer acetate - solution for injection - glatiramer acetate 40 mg - immunostimulants

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharmaceuticals limited - glatiramer acetate - solution for injection - 40 mg/ml - other immunostimulants - antineoplastic and immunomodulating agents, immunostimulants - it is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see section 5.1 for important information on the population for which efficacy has been established). copaxone is not indicated in primary or secondary progressive ms.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - orf virus - lyophilisate for suspension for injection - immunomodulator - horses